BAPI was formed in 1972

Currently 154 pharmaceutical companies are active registered members

Plays a key role in developing the pharma sector through various initiatives

Ensures supply of safe and quality medicines at affordable price for almost 50 years

Pharma market has grown from about $25 million in 1982 to about $3.2 Bn, today

BAPI members account for 98% of the total production

Leading companies have nearly all major GMP accreditation like USFDA, UK MHRA, EU GMP, Health Canada, TGA Australia, ANVISA Brazil, GCC etc.

Members exporting to more than 150 countries; many renowned hospitals and institutes

MoUs in place with pharma association of different countries

A member of International Federation of Pharmaceutical Manufacturers Association (IFPMA)

BAPI has been successfully representing the country’s pharma industry to various global forums

The Industry is one of the largest white collar employers in the country.

BAPI continually makes efforts to strengthen the capabilities in order to improve and maintain its competitiveness